Abbott Laboratories financial data

Symbol
ABT on NYSE
Industry
Pharmaceutical Preparations
Location
100 Abbott Park Road, Abbott Park, IL
State of incorporation
IL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 166 % -2.06%
Quick Ratio 49.1 % +11.5%
Return On Equity 14.3 % +2.36%
Return On Assets 7.64 % +8.98%
Operating Margin 15.9 % +4.53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.74B shares +0.26%
Entity Public Float 185B USD -0.5%
Common Stock, Value, Issued 24.9B USD +1%
Weighted Average Number of Shares Outstanding, Basic 1.74B shares +0.15%
Weighted Average Number of Shares Outstanding, Diluted 1.75B shares +0.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 40.7B USD +1.24%
Research and Development Expense 2.75B USD -4.24%
Costs and Expenses 34.2B USD +0.42%
Operating Income (Loss) 6.48B USD +5.83%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.51B USD +3.71%
Income Tax Expense (Benefit) 952M USD -14.6%
Net Income (Loss) Attributable to Parent 5.56B USD +7.67%
Earnings Per Share, Basic 3.18 USD/shares +7.8%
Earnings Per Share, Diluted 3.17 USD/shares +8.19%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.99B USD -10.8%
Accounts Receivable, after Allowance for Credit Loss, Current 6.85B USD +11.1%
Inventory, Net 6.81B USD -0.83%
Assets, Current 23.1B USD -1.64%
Property, Plant and Equipment, Net 10.2B USD +8.3%
Operating Lease, Right-of-Use Asset 1.12B USD +0.54%
Intangible Assets, Net (Excluding Goodwill) 7.83B USD -20.4%
Goodwill 23.3B USD +0.22%
Assets 73B USD -0.46%
Employee-related Liabilities, Current 1.39B USD +1.98%
Liabilities, Current 13.8B USD -4.11%
Operating Lease, Liability, Noncurrent 949M USD +0.64%
Other Liabilities, Noncurrent 3.47B USD -8.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.14B USD -0.79%
Retained Earnings (Accumulated Deficit) 38.4B USD +5.5%
Stockholders' Equity Attributable to Parent 39.3B USD +5.77%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 39.6B USD +5.76%
Liabilities and Equity 73B USD -0.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.03B USD -10.3%
Net Cash Provided by (Used in) Financing Activities -1.18B USD +16.6%
Net Cash Provided by (Used in) Investing Activities -425M USD +8.01%
Common Stock, Shares Authorized 2.4B shares 0%
Common Stock, Shares, Issued 1.99B shares +0.14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -612M USD +15.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.99B USD -10.8%
Deferred Tax Assets, Valuation Allowance 8.69B USD +643%
Deferred Tax Assets, Gross 11.6B USD +197%
Operating Lease, Liability 1.19B USD +1.79%
Depreciation 333M USD +5.71%
Payments to Acquire Property, Plant, and Equipment 398M USD +4.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.49B USD -5.23%
Lessee, Operating Lease, Liability, to be Paid 1.36B USD +1.57%
Property, Plant and Equipment, Gross 22.1B USD +5.42%
Operating Lease, Liability, Current 245M USD +6.52%
Lessee, Operating Lease, Liability, to be Paid, Year Two 246M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 278M USD +7.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +34.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 168M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 206M USD +13.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 1.34B USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 146M USD -3.31%
Amortization of Intangible Assets 1.92B USD -3.18%
Deferred Tax Assets, Net of Valuation Allowance 2.86B USD +5.3%
Interest Expense 625M USD +7.76%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%